Clinical trial

Assessing the Effectiveness of Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery (AIMS)

Name
Ibuprofen vs. Morphine
Description
Morphine is now the most commonly used opioid in children for pain management even though the safety of morphine use in children is a primary concern for parents as it is perceived to have more associated risks. Ibuprofen and other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) have also been shown to be effective for the management of postoperative pain with fewer associated adverse effects. However, there have been concerns that utilization of ibuprofen alone may lead to inadequate pain management. Evidence of whether ibuprofen is equally effective as morphine for postoperative pain control in pediatric inguinal surgery is lacking and needs to be further explored as a measure to potentially reduce opioid exposure in children. To determine which drug is more effective for relieving post-operative pain, this trial will compare the effectiveness of ibuprofen and morphine at reducing post-operative pain, and the amount of analgesic use required post-surgery.
Trial arms
Trial start
2017-02-27
Estimated PCD
2024-02-01
Trial end
2024-02-01
Status
Recruiting
Treatment
Ibuprofen
(10mg/kg; maximum 600 mg) every six hours as needed
Arms:
Ibuprofen suspension
Other names:
Advil
Morphine
0.2 mg/ kg morphine suspension (maximum 10mg) every four hours as needed
Arms:
Morphine Sulfate suspension
Other names:
Morphine sulfate
Size
100
Primary endpoint
Pain scales Post-Discharge from Hospital
Postoperative pain will be measured at three time the evening of the procedure, 24 hours post-discharge and 48 hours post-discharge) using the validated Parents Postoperative Pain Measure (PPPM)
Eligibility criteria
Inclusion Criteria: 1. Pediatric Patients between the ages of 10 months-5 years at presentation to clinic 2. Patients diagnosed with inguinal hernia or hydrocele, or undescended testes requiring surgical intervention by a trained physician 3. Patients requiring inguinal day surgery Exclusion Criteria: 1. Patients who have undergone previous inguinal surgery 2. Patients with other co-morbidities 3. Patients unable to be prescribed Ibuprofen or Morphine 4. Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDS) or opioids 5. Patients with renal or hepatic failure 6. Patients with coagulation disorders 7. Deviation to pre-established anesthesia protocol 8. Patients diagnosed with asthma or restrictive airways
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}
Updated at
2023-03-15

1 organization

2 products

1 indication

Product
Ibuprofen
Product
Morphine